DexCom, Inc. (DXCM) Stock Price

DXCMStockS&P 500

$86.04+29.72%52W

Market Cap$32.47B

P/E38.82x

PEG Ratio2.19

Div yield—

Beta1.44

DXCM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)26.77%

Price vs S&P 500 (4W)-2.19%

PEG Ratio2.19

VGM Score64.99

P/E Ratio (Annual)38.82x

P/CF (Annual)22.54x

Book Value / Share (Quarterly)$6.95

P/TBV (Annual)9.68x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)17.01%

Cash Flow / Share (Quarterly)$3.72

Price vs S&P 500 (YTD)17.71%

Gross Margin (TTM)64.34%

Net Profit Margin (TTM)20.12%

EPS (TTM)$2.51

10-Day Avg Trading Volume3.51M

EPS Excl Extra (TTM)$2.51

Revenue Growth (5Y)19.33%

EPS (Annual)$2.06

ROI (Annual)20.70%

Gross Margin (Annual)62.09%

Net Profit Margin (5Y Avg)13.55%

Cash / Share (Quarterly)$5.16

P/E Basic Excl Extra (TTM)32.48x

Revenue Growth QoQ (YoY)13.08%

EPS Growth (5Y)9.54%

P/E Normalized (Annual)38.82x

ROA (Last FY)13.19%

Revenue Growth TTM (YoY)15.54%

EBITD / Share (TTM)$3.53

ROE (5Y Avg)22.13%

Operating Margin (TTM)22.92%

Cash Flow / Share (Annual)$2.80

P/B Ratio12.39x

P/B Ratio (Quarterly)9.91x

Net Income / Employee (Annual)$76,000

EV / Revenue (TTM)6.57x

Net Interest Coverage (TTM)978.00x

ROA (TTM)14.85%

EPS Growth QoQ (YoY)44.97%

EV / EBITDA (TTM)23.27x

EPS Incl Extra (Annual)$2.06

Current Ratio (Annual)1.88x

Quick Ratio (Quarterly)1.40x

3-Month Avg Trading Volume4.52M

52-Week Price Return29.72%

EV / Free Cash Flow (Annual)30.32x

P/E Incl Extra (TTM)32.48x

Revenue / Employee (TTM)$451,700

Tangible BV / Share (Quarterly)$6.64

P/S Ratio (Annual)6.96x

Asset Turnover (Annual)0.74x

52-Week High$92.59

Operating Margin (5Y Avg)15.05%

EPS Excl Extra (Annual)$2.06

CapEx CAGR (5Y)12.81%

Tangible BV CAGR (5Y)56.65%

26-Week Price Return36.68%

Quick Ratio (Annual)1.56x

13-Week Price Return12.25%

Total Debt / Equity (Annual)0.47x

Current Ratio (Quarterly)1.73x

Enterprise Value$32.66B

Revenue / Share Growth (5Y)20.19%

Asset Turnover (TTM)0.74x

Book Value / Share Growth (5Y)8.47%

Revenue / Employee (Annual)$423,800

Inventory Turnover (Annual)3.02x

Pretax Margin (Annual)23.35%

Cash / Share (Annual)$5.19

3-Month Return Std Dev38.41%

Gross Margin (5Y Avg)64.50%

Net Income / Employee (TTM)$90,900

EBITDA CAGR (5Y)30.97%

EBITDA Interim CAGR (5Y)25.43%

ROE (Last FY)30.46%

Net Interest Coverage (Annual)32.41x

EPS Basic Excl Extra (Annual)$2.06

P/FCF (TTM)23.11x

Receivables Turnover (TTM)3.81x

EV / Free Cash Flow (TTM)23.24x

Total Debt / Equity (Quarterly)0.49x

EPS Incl Extra (TTM)$2.51

Receivables Turnover (Annual)4.20x

ROI (TTM)22.93%

P/S Ratio (TTM)6.53x

Pretax Margin (5Y Avg)16.89%

Revenue / Share (Annual)$11.50

Tangible BV / Share (Annual)$6.95

Forward P/E29.84x

Free OCF CAGR (5Y)31.25%

Price vs S&P 500 (52W)14.18%

P/E Ratio (TTM)32.48x

EPS Growth TTM (YoY)79.40%

Year-to-Date Return29.64%

5-Day Price Return0.14%

EPS Normalized (Annual)$2.06

ROA (5Y Avg)8.29%

Net Profit Margin (Annual)17.94%

Month-to-Date Return-0.29%

Cash Flow / Share (TTM)$1.28

EBITD / Share (Annual)$2.87

EPS Growth (3Y)37.23%

Operating Margin (Annual)19.56%

LT Debt / Equity (Annual)0.45x

P/CF (TTM)18.57x

ROI (5Y Avg)11.71%

P/E Excl Extra (TTM)32.48x

LT Debt / Equity (Quarterly)0.47x

EPS Basic Excl Extra (TTM)$2.51

P/TBV (Quarterly)10.38x

P/B Ratio (Annual)9.43x

Inventory Turnover (TTM)2.73x

Pretax Margin (TTM)25.76%

Book Value / Share (Annual)$7.14

Price vs S&P 500 (13W)9.57%

Net Margin Growth (5Y)-8.86%

Beta1.44x

P/FCF (Annual)30.14x

Revenue / Share (TTM)$12.74

ROE (TTM)36.19%

52-Week Low$54.11

vGradeC

gGradeB

mGradeB

vgmGradeB

DXCM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 30, 2026	$0.61	$0.70	+15.11%(+$0.09)
Q1 2026	Apr 30, 2026	$0.47	$0.56	+18.99%(+$0.09)
Q4 2025	Feb 12, 2026	$0.65	$0.68	+4.50%(+$0.03)
Q3 2025	Oct 30, 2025	$0.57	$0.61	+7.51%(+$0.04)
Q2 2025	Jul 30, 2025	$0.44	$0.48	+8.25%(+$0.04)

DXCM Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.27

4.26

4.28

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About DexCom, Inc.

DexCom manufactures continuous glucose monitoring systems that provide an alternative to traditional blood glucose testing for diabetes management. The company's CGM technology integrates with insulin pumps from Insulet and Tandem to enable automated insulin delivery. Products are distributed through medical equipment distributors and retail pharmacies.

DXCM Next Earnings Report

Report dateOct 29, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.67

Revenue estimate$1.33B

Also reporting on Oct 29, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

DXCM Insider Transactions

SellSep 28, 2026
STERN SADIE
Officer
Shares: 2,565Value: $220,975
SellSep 15, 2026
AUGUSTINOS NICHOLAS
Director
Shares: 8,089Value: $679,769
SellSep 15, 2026
BROWN MICHAEL JON
Officer
Shares: 1,700Value: $142,868
SellSep 10, 2026
SYLVAIN JEREME M
Chief Financial Officer
Shares: 3,638Value: $302,936
SellAug 27, 2026
STERN SADIE
Officer
Shares: 2,565Value: $226,669

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

DXCM News

The Big 3 Trade Setups: Parker Hannifin, DexCom, and Union PacificAug 20, 2026

All market news

Companies in Related Industries

WATWaters CorpLab Analytical Instruments
ILMNIllumina IncLab Analytical Instruments
ROPRoper Technologies, Inc. Common StockIndustrial Instruments
MTDMettler-Toledo InternationalLab Analytical Instruments
ALCAlcon Inc. Ordinary SharesOphthalmic Goods
GEHCGE HealthCare Technologies Inc. Common StockX-Ray Equipment
TDYTeledyne Technologies IncorporatedDefense Systems & Equipment
PHGKONINKLIJKE PHILIPS N.V.X-Ray Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$54.11

High$92.59